Skip to main content

Table 2 Demographics of patients with SpA across Latin America

From: Prevalence, demographics, and clinical characteristics of Latin American patients with spondyloarthritis

Country

Study

Patients with SpA (n)

Male (%)

Age (y)

Race (%)

Family history of SpA (%)

Diagnosis (%)

Age at disease onset (y)

Disease duration (y)

AS

PsA

uSpA

ReA

IBD-SpA

Argentina

Marengo et al., 2008 [17]

61

90.2

43*

n/r

n/r

100

0

0

0

0

n/r

n/r

Bellomio et al., 2008 [18]

405

59

48.1

71 (W)

23 (WI)

16.4

30.3

46.7

12.4

6.3

0.7

38.4

9.7a

Buschiazzo et al., 2011 [19]

402

59

48.3*

70.8 (W)

22.8 (WI)

16.8

21.4

60.2

8.2

6.2

2.5

n/r

8*

Soriano et al., 2011 [20]

65

63.1

n/r

92–96 (W)b

2–4 (Asian)b

n/r

0

100

0

0

0

40.3

8.5

Schneeberger et al., 2015 [21]

73

49.3

49*

n/r

n/r

0

100

0

0

0

43*

6*

Sommerfleck et al., 2018a [22]

86

80

46*

n/r

n/r

n/r c

n/r c

n/r c

n/r c

n/r c

n/r

19*

Sommerfleck et al., 2018b [23]

50

80

47*

n/r

n/r

70

28

0

0

0

n/r

13*

Scarafia et al., 2016 (CA) [24]

92

46.7

47.7

n/r

n/r

0

100

0

0

0

n/r

3

Capelusnik et al., 2018 (CA) [25]

231

75.3

46*

n/r

n/r

n/r c

n/r c

n/r c

n/r c

n/r c

n/r c

20.5*

Brazil

Sampaio-Barros et al., 2008 [26]

1036

73.6

43.7

59.5 (W)

25.9 (AB)

16.2

72.3

13.7

6.3

3.6

1.0

31

12.7a

Skare et al., 2012a [27]

1318

71.9

n/r

65.0 (W)

31.3 (AB)

15.9

65.1

18.3

6.8

3.5

3.5

n/r

14.2

Skare et al., 2012b [28]

1424

75.9 (< 40 y)

60.6 (≥40 y)

n/r

n/r

19.2 (< 40 y)

13.1 (≥40 y)

66.3

18

6.7

5.5

3.5

28.6

n/r

Rodrigues et al., 2012 [29]

1472

n/r

n/r

n/r

n/r

65.4

18.4

6.7

3.3

3.3

n/r

n/r

Duarte et al., 2014 [30]

1189

70.6

44.5

57.7 (W)

42.3 (NW)

n/r

n/r

n/r

n/r

n/r

n/r

n/r

n/r

Ribeiro et al., 2018 [31]

202

64.2

48.6

62.4 (W)

37.6 (NW)

19.3

71.3d

28.7d

0

0

0

n/r

17.2

Simioni et al., (2019) [32]

85

64.7%

49.3*

76.4% (W)

23.5% (AB)

n/r

61.1

21.1

5.8

1.1

0

n/r

14*

Henrique et al., 2018 (CA) [33]

82

50

56

n/r

n/r

0

100

0

0

0

n/r

9.4

Chile

Gutiérrez et al., 2008 [34]

109

58.4

42

16.8 (W)

64.6 (WI)

13.3

58.7

25.6

7.3

0.9

5.5

35.3

7.1

Ibáñez et al., 2019 (CA) [35]

472

36.7

42

n/r

n/r

n/r

n/r

n/r

n/r

n/r

n/r

n/r

Colombia

Valle-Onate et al., 2011 [36]

279

69.9

n/r

n/r

n/r

34.4

3.6

39.1

18.3

0.4

n/r

n/r

Bautista-Molano et al., 2016 [37]

581

71.7

35

n/r

5.3

29.1

3.6

39.6

26.9

0.9

28

7.3

Santos et al., 2017 [38]

189

63.8

35.9

n/r

n/r

46.0

0

35.5

18.5

0

n/r

n/r

Costa Rica

Sáenz Castro et al., 2008 [39]

33

57.6

41.3

21.2 (W)

66.7 (WI)

12.2

45.5

6.1

45.5

0

0

34.5

6.8a

Mexico

Casasola-Vargas et al., 2008 [40]

172

59.3

38.1

18.5 (W)

76.3 (WI)

18.6

34.9

8.7

11.6

1.7

1.2

28.0

10.1a

Peláez-Ballestas et al., 2013 [12]

28

50

40.7

n/r

21.4

n/r

n/r

n/r

n/r

n/r

n/r

n/r

Peru

Chávez-Corrales et al., 2008 [41]

60

65

40.3

3.3 (W)

93.3 (WI)

18.6

53

6.7

13.3

1.7

0

30.6

9.7a

Uruguay

Palleiro and Spangenberg, 2008 [42]

53

66.0

41.2

86.8 (W)

11.3 (MR)

13.2

53

17

19

0

4

31.0

10.2a

Venezuela

Chacón et al., 2008 [43]

69

62.3

40.9

31.9 (W)

39.1 (MR)

27.5

55.1

21.7

11.6

0

4.3

29.4

11.5a

Multinational

García-Kutzbach et al., 2011 [44]

233

46

47.5*

n/r

n/r

10

9

33

47.2

0.8

n/r

n/r

Benegas et al., 2012 [45]

1083

75

43

n/r

n/r

100

0

0

0

0

28

n/r

Bautista-Molano et al., 2018 [46]

390

64

45

n/r

n/r

n/r

n/r

n/r

n/r

n/r

n/r

7.0

  1. Continuous values are mean unless indicated (*) as median
  2. References are articles unless indicated as conference abstracts (CA)
  3. aInformation not available in original RESPONDIA publication; data taken from Gallinaro et al., 2010 [5].
  4. bData for the 2 regional populations (Autonomous City of Buenos Aires, membership of the Hospital Italiano Medical Care Program) were presented separately.
  5. cPatients were described as having axial spondyloarthritis.
  6. dPatients were classified as having either axial SpA which was predominantly AS, or peripheral SpA which was predominantly PsA.
  7. AB African-Brazilian (could include MR), AS ankylosing spondylitis, CA conference abstract, I Indigenous, n number of patients with specified condition, MR mixed race (white-black), n/r not reported, NW non-white, O Other; PsA psoriatic arthritis, ReA reactive arthritis, SpA spondyloarthritis, T total population, uSpA undifferentiated spondyloarthritis, W White, WI White-Indigenous, y years
Back to article page

Advances in Rheumatology

ISSN: 2523-3106